Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

50.42
+2.575.37%
Pre-market: 50.680.2600+0.52%08:16 EDT
Volume:453.10K
Turnover:22.50M
Market Cap:3.60B
PE:-42.89
High:50.71
Open:47.47
Low:47.47
Close:47.85
52wk High:50.71
52wk Low:12.56
Shares:71.32M
Float Shares:20.81M
Volume Ratio:1.05
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1756
EPS(LYR):-1.0800
ROE:-78.49%
ROA:-44.34%
PB:36.14
PE(LYR):-46.69

Loading ...

BRIEF-Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System

Reuters
·
Apr 26

Pulse Biosciences nPulse catheter posts 96% AF ablation success at one year

Reuters
·
Apr 26

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

TIPRANKS
·
Apr 20

Pulse Biosciences to present one-year nsPFA atrial fibrillation study outcomes at HRS 2026

Reuters
·
Apr 20

Pulse Biosciences to host analyst event after Heart Rhythm Society late-breaking data presentation

Reuters
·
Apr 17

Pulse Biosciences Targets Thyroid Nodules With New Device Study, Eyeing a Minimally Invasive Niche

TIPRANKS
·
Apr 17

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy

TIPRANKS
·
Apr 16

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story?

Simply Wall St.
·
Apr 12

BRIEF-Pulse Biosciences Strengthens Executive Leadership Team

Reuters
·
Apr 09

Pulse Biosciences names Liane Teplitsky chief operating officer

Reuters
·
Apr 09

Affluent Medical names Anne Lange to board, replaces Soad El Gazaoui

Reuters
·
Apr 09

Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study

TIPRANKS
·
Apr 07

Pulse Biosciences enrolls first patients in NANOPULSE-AF pivotal trial for AF ablation system

Reuters
·
Apr 07

Pulse Biosciences Enrolls First Patients in Nanopulse-Af Ide Pivotal Clinical Study Evaluating Npulse™ Cardiac Catheter System for Atrial Fibrillation

THOMSON REUTERS
·
Apr 07

Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge?

Simply Wall St.
·
Apr 03

Pulse Biosciences to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 03

Pulse Biosciences Grants RSUs to Chief Technology Officer

TIPRANKS
·
Mar 28

Pulse Biosciences awards CTO Darrin R. Uecker 100,000 restricted stock units; grant vests in full on third anniversary

Reuters
·
Mar 28

Assessing Pulse Biosciences (PLSE) Valuation After The nPulse Cardiac Catheter Ablation Pivot

Simply Wall St.
·
Mar 23

BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data

Reuters
·
Mar 17